Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

In response to the letter "[11C]raclopride and extrastriatal binding to D2/3 receptors".

Svensson JE, Schain M, Plavén-Sigray P, Cervenka S, Tiger M, Nord M, Halldin C, Farde L, Lundberg J.

Neuroimage. 2019 Nov 20:116371. doi: 10.1016/j.neuroimage.2019.116371. [Epub ahead of print] No abstract available.

2.

Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise.

Matheson GJ, Plavén-Sigray P, Tuisku J, Rinne J, Matuskey D, Cervenka S.

Eur J Nucl Med Mol Imaging. 2019 Nov 12. doi: 10.1007/s00259-019-04541-y. [Epub ahead of print] No abstract available.

PMID:
31713656
3.

Common brain disorders are associated with heritable patterns of apparent aging of the brain.

Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Carlo P, Djurovic S, Dørum ES, Eisenacher S, Elvsåshagen T, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B, Frei O, Haatveit B, Håberg AK, Harbo HF, Hartman CA, Heslenfeld D, Hoekstra PJ, Høgestøl EA, Jernigan TL, Jonassen R, Jönsson EG; Karolinska Schizophrenia Project (KaSP), Kirsch P, Kłoszewska I, Kolskår KK, Landrø NI, Hellard S, Lesch KP, Lovestone S, Lundervold A, Lundervold AJ, Maglanoc LA, Malt UF, Mecocci P, Melle I, Meyer-Lindenberg A, Moberget T, Norbom LB, Nordvik JE, Nyberg L, Oosterlaan J, Papalino M, Papassotiropoulos A, Pauli P, Pergola G, Persson K, Richard G, Rokicki J, Sanders AM, Selbæk G, Shadrin AA, Smeland OB, Soininen H, Sowa P, Steen VM, Tsolaki M, Ulrichsen KM, Vellas B, Wang L, Westman E, Ziegler GC, Zink M, Andreassen OA, Westlye LT.

Nat Neurosci. 2019 Oct;22(10):1617-1623. doi: 10.1038/s41593-019-0471-7. Epub 2019 Sep 24.

PMID:
31551603
4.

Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain.

Svensson JE, Schain M, Plavén-Sigray P, Cervenka S, Tiger M, Nord M, Halldin C, Farde L, Lundberg J.

Neuroimage. 2019 Nov 15;202:116143. doi: 10.1016/j.neuroimage.2019.116143. Epub 2019 Aug 29.

PMID:
31473354
5.

Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study.

Tuisku J, Plavén-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Brück A, Carson RE, Chen MK, Cosgrove KP, Ekblad L, Esterlis I, Farde L, Forsberg A, Halldin C, Helin S, Kosek E, Lekander M, Lindgren N, Marjamäki P, Rissanen E, Sucksdorff M, Varrone A; HRRT [11C ]PBR28 study group, Collste K, Gallezot JD, Hillmer A, Huang Y, Höglund CO, Johansson J, Jucaite A, Lampa J, Nabulsi N, Pittman B, Sandiego CM, Stenkrona P, Rinne J, Matuskey D, Cervenka S.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2329-2338. doi: 10.1007/s00259-019-04403-7. Epub 2019 Jul 30.

6.

Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [11C]PBR28 positron emission tomography.

Forsberg A, Lampa J, Estelius J, Cervenka S, Farde L, Halldin C, Lekander M, Olgart Höglund C, Kosek E.

J Neuroimmunol. 2019 Sep 15;334:577000. doi: 10.1016/j.jneuroim.2019.577000. Epub 2019 Jun 22.

7.
8.

Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk.

Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, Fatouros-Bergman H, Flyckt L, Di Giorgio A, Haatveit B, Jönsson EG, Kirsch P, Lund MJ, Meyer-Lindenberg A, Pergola G, Schwarz E, Smeland OB, Quarto T, Zink M, Andreassen OA, Westlye LT; Karolinska Schizophrenia Project Consortium.

JAMA Psychiatry. 2019 Jul 1;76(7):739-748. doi: 10.1001/jamapsychiatry.2019.0257. Erratum in: JAMA Psychiatry. 2019 Jul 17;:.

PMID:
30969333
9.

D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.

Stenkrona P, Matheson GJ, Halldin C, Cervenka S, Farde L.

Int J Neuropsychopharmacol. 2019 Jul 1;22(7):415-425. doi: 10.1093/ijnp/pyz017.

10.

Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears?

Plavén-Sigray P, Cervenka S.

Psychol Med. 2019 Jul;49(10):1624-1628. doi: 10.1017/S003329171800421X. Epub 2019 Feb 11. No abstract available. Erratum in: Psychol Med. 2019 Jul;49(9):1583-1584.

11.

Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis.

Santillo AF, Lundgren S, Xu C, Orhan F, Fatouros-Bergman H, Blennow K, Zetterberg H, Portelius E; Karolinska Schizophrenia Project (KaSP) Consortium, Cervenka S, Jönsson EG, Erhardt S, Engberg G.

Schizophr Res. 2019 Jun;208:490-492. doi: 10.1016/j.schres.2019.01.010. Epub 2019 Feb 4. No abstract available.

PMID:
30733168
12.

Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder.

Schwarz E, Doan NT, Pergola G, Westlye LT, Kaufmann T, Wolfers T, Brecheisen R, Quarto T, Ing AJ, Di Carlo P, Gurholt TP, Harms RL, Noirhomme Q, Moberget T, Agartz I, Andreassen OA, Bellani M, Bertolino A, Blasi G, Brambilla P, Buitelaar JK, Cervenka S, Flyckt L, Frangou S, Franke B, Hall J, Heslenfeld DJ, Kirsch P, McIntosh AM, Nöthen MM, Papassotiropoulos A, de Quervain DJ, Rietschel M, Schumann G, Tost H, Witt SH, Zink M, Meyer-Lindenberg A; IMAGEMEND Consortium, Karolinska Schizophrenia Project (KaSP) Consortium.

Transl Psychiatry. 2019 Jan 17;9(1):12. doi: 10.1038/s41398-018-0225-4.

13.

Increased peripheral levels of TARC/CCL17 in first episode psychosis patients.

Malmqvist A, Schwieler L, Orhan F, Fatouros-Bergman H, Bauer M, Flyckt L, Cervenka S, Engberg G, Piehl F; Karolinska Schizophrenia Project (KaSP) consortium, Erhardt S.

Schizophr Res. 2019 Aug;210:221-227. doi: 10.1016/j.schres.2018.12.033. Epub 2019 Jan 3.

PMID:
30612841
14.

Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men.

Caravaggio F, Plavén-Sigray P, Matheson GJ, Plitman E, Chakravarty MM, Borg J, Graff-Guerrero A, Cervenka S.

PLoS One. 2018 Dec 20;13(12):e0209584. doi: 10.1371/journal.pone.0209584. eCollection 2018.

15.

Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region.

Plavén-Sigray P, Schain M, Zanderigo F; Karolinska [(11)C]PBR28 study group, Rabiner EA, Gunn RN, Ogden RT, Cervenka S.

Neuroimage. 2019 Mar;188:102-110. doi: 10.1016/j.neuroimage.2018.11.020. Epub 2018 Nov 27.

16.

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function.

Plavén-Sigray P, Matheson GJ, Cselényi Z, Jucaite A, Farde L, Cervenka S.

EJNMMI Res. 2018 Nov 29;8(1):102. doi: 10.1186/s13550-018-0455-8.

17.

Serotonin 5-HT1A receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing.

Griffioen G, Matheson GJ, Cervenka S, Farde L, Borg J.

PeerJ. 2018 Nov 16;6:e5790. doi: 10.7717/peerj.5790. eCollection 2018.

18.

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.

Mak E, Bethlehem RAI, Romero-Garcia R, Cervenka S, Rittman T, Gabel S, Surendranathan A, Bevan-Jones RW, Passamonti L, Vázquez Rodríguez P, Su L, Arnold R, Williams GB, Hong YT, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Alzheimers Dement (Amst). 2018 Sep 17;10:678-687. doi: 10.1016/j.dadm.2018.08.005. eCollection 2018.

19.

Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.

Albrecht DS, Forsberg A, Sandström A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, Höglund CO, Catana C, Cervenka S, Akeju O, Lekander M, Cohen G, Halldin C, Taylor N, Kim M, Hooker JM, Edwards RR, Napadow V, Kosek E, Loggia ML.

Brain Behav Immun. 2019 Jan;75:72-83. doi: 10.1016/j.bbi.2018.09.018. Epub 2018 Sep 14.

20.

Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.

Orhan F, Schwieler L, Fatouros-Bergman H, Malmqvist A, Cervenka S, Collste K, Flyckt L, Farde L, Sellgren CM, Piehl F; Karolinska Schizophrenia Project (KaSP) Consortium, Engberg G, Erhardt S.

Acta Psychiatr Scand. 2018 Nov;138(5):432-440. doi: 10.1111/acps.12944. Epub 2018 Aug 21.

PMID:
30132802
21.

Immune sculpting of the psychotic brain? In vivo associations between a glial cell marker and hippocampal morphology.

Cervenka S.

Brain Behav Immun. 2018 Nov;74:43-44. doi: 10.1016/j.bbi.2018.08.004. Epub 2018 Aug 2. No abstract available.

PMID:
30077591
22.

[11C]SCH23390 binding to the D1-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis.

Stenkrona P, Matheson GJ, Cervenka S, Sigray PP, Halldin C, Farde L.

EJNMMI Res. 2018 Aug 2;8(1):74. doi: 10.1186/s13550-018-0416-2.

23.

Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging.

Petrov D, Gutman BA, Yu SJ, van Erp TGM, Turner JA, Schmaal L, Veltman D, Wang L, Alpert K, Isaev D, Zavaliangos-Petropulu A, Ching CRK, Calhoun V, Glahn D, Satterthwaite TD, Andreasen OA, Borgwardt S, Howells F, Groenewold N, Voineskos A, Radua J, Potkin SG, Crespo-Facorro B, Tordesillas-Gutiérrez D, Shen L, Lebedeva I, Spalletta G, Donohoe G, Kochunov P, Rosa PGP, James A, Dannlowski U, Baune BT, Aleman A, Gotlib IH, Walter H, Walter M, Soares JC, Ehrlich S, Gur RC, Doan NT, Agartz I, Westlye LT, Harrisberger F, Riecher-Rössler A, Uhlmann A, Stein DJ, Dickie EW, Pomarol-Clotet E, Fuentes-Claramonte P, Canales-Rodríguez EJ, Salvador R, Huang AJ, Roiz-Santiañez R, Cong S, Tomyshev A, Piras F, Vecchio D, Banaj N, Ciullo V, Hong E, Busatto G, Zanetti MV, Serpa MH, Cervenka S, Kelly S, Grotegerd D, Sacchet MD, Veer IM, Li M, Wu MJ, Irungu B, Walton E, Thompson PM.

Mach Learn Med Imaging. 2017 Sep;10541:371-378. doi: 10.1007/978-3-319-67389-9_43. Epub 2017 Sep 7.

24.

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.

Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S.

Biol Psychiatry. 2018 Sep 15;84(6):433-442. doi: 10.1016/j.biopsych.2018.02.1171. Epub 2018 Mar 6.

25.

Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients.

Checa A, Malmqvist A, Flyckt L, Schwieler L, Samuelsson M, Skogh E, Cervenka S, Dahl ML, Piehl F; Karolinska Schizophrenia Project (KaSP) Consortium, Erhardt S, Wheelock CE.

Schizophr Res. 2018 Sep;199:438-441. doi: 10.1016/j.schres.2018.03.029. Epub 2018 Apr 4. No abstract available.

PMID:
29627172
26.

Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study.

Plavén-Sigray P, Matheson GJ, Gustavsson P, Stenkrona P, Halldin C, Farde L, Cervenka S.

PLoS One. 2018 Mar 15;13(3):e0193770. doi: 10.1371/journal.pone.0193770. eCollection 2018.

27.

PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders.

Cervenka S.

Neurosci Lett. 2019 Jan 19;691:26-34. doi: 10.1016/j.neulet.2018.03.007. Epub 2018 Mar 5. Review.

28.

Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders.

Farde L, Plavén-Sigray P, Borg J, Cervenka S.

Philos Trans R Soc Lond B Biol Sci. 2018 Apr 19;373(1744). pii: 20170156. doi: 10.1098/rstb.2017.0156. Review.

29.

Evidence of fatigue, disordered sleep and peripheral inflammation, but not increased brain TSPO expression, in seasonal allergy: A [11C]PBR28 PET study.

Tamm S, Cervenka S, Forsberg A, Estelius J, Grunewald J, Gyllfors P, Karshikoff B, Kosek E, Lampa J, Lensmar C, Strand V, Åkerstedt T, Halldin C, Ingvar M, Olgart Höglund C, Lekander M.

Brain Behav Immun. 2018 Feb;68:146-157. doi: 10.1016/j.bbi.2017.10.013. Epub 2017 Oct 18.

30.

First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction.

Orhan F, Fatouros-Bergman H, Schwieler L, Cervenka S, Flyckt L, Sellgren CM; Karolinska Schizophrenia Project (KaSP) consortium, Engberg G, Erhardt S.

Schizophr Res. 2018 May;195:406-408. doi: 10.1016/j.schres.2017.09.016. Epub 2017 Sep 23. No abstract available.

PMID:
28951075
31.

Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data.

Matheson GJ, Plavén-Sigray P, Forsberg A, Varrone A, Farde L, Cervenka S.

EJNMMI Res. 2017 Dec;7(1):58. doi: 10.1186/s13550-017-0304-1. Epub 2017 Jul 21.

32.

Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.

Jayaram-Lindström N, Guterstam J, Häggkvist J, Ericson M, Malmlöf T, Schilström B, Halldin C, Cervenka S, Saijo T, Nordström AL, Franck J.

Transl Psychiatry. 2017 Apr 25;7(4):e1104. doi: 10.1038/tp.2017.79.

33.

Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [11C]SCH-23390.

Matheson GJ, Stenkrona P, Cselényi Z, Plavén-Sigray P, Halldin C, Farde L, Cervenka S.

Neuroimage. 2017 Jul 15;155:344-353. doi: 10.1016/j.neuroimage.2017.04.031. Epub 2017 Apr 15.

34.

Extrastriatal dopamine D2-receptor availability in social anxiety disorder.

Plavén-Sigray P, Hedman E, Victorsson P, Matheson GJ, Forsberg A, Djurfeldt DR, Rück C, Halldin C, Lindefors N, Cervenka S.

Eur Neuropsychopharmacol. 2017 May;27(5):462-469. doi: 10.1016/j.euroneuro.2017.03.007. Epub 2017 Apr 2.

35.

In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.

Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O'Brien JT.

Ageing Res Rev. 2017 Jul;36:50-63. doi: 10.1016/j.arr.2017.03.002. Epub 2017 Mar 15. Review.

PMID:
28315409
36.

CSF GABA is reduced in first-episode psychosis and associates to symptom severity.

Orhan F, Fatouros-Bergman H, Goiny M, Malmqvist A, Piehl F; Karolinska Schizophrenia Project (KaSP) Consortium, Cervenka S, Collste K, Victorsson P, Sellgren CM, Flyckt L, Erhardt S, Engberg G.

Mol Psychiatry. 2018 May;23(5):1244-1250. doi: 10.1038/mp.2017.25. Epub 2017 Mar 14.

37.

The immune response of the human brain to abdominal surgery.

Forsberg A, Cervenka S, Jonsson Fagerlund M, Rasmussen LS, Zetterberg H, Erlandsson Harris H, Stridh P, Christensson E, Granström A, Schening A, Dymmel K, Knave N, Terrando N, Maze M, Borg J, Varrone A, Halldin C, Blennow K, Farde L, Eriksson LI.

Ann Neurol. 2017 Apr;81(4):572-582. doi: 10.1002/ana.24909. Epub 2017 Apr 11.

38.

[Comparing of Treatment Results of Monocanalicular and Bicanalicular Intubation in Inborn Lacrimal Duct Obstruction].

Červenka S, Matoušek P, Komínek P.

Cesk Slov Oftalmol. Fall 2016;72(5):178-181. Czech.

39.

Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.

Collste K, Plavén-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, Amini N, Aeinehband S; Karolinska Schizophrenia Project (KaSP) consortium, Erhardt S, Halldin C, Flyckt L, Farde L, Cervenka S.

Mol Psychiatry. 2017 Jun;22(6):850-856. doi: 10.1038/mp.2016.247. Epub 2017 Feb 14.

PMID:
28194003
40.

Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.

Borg J, Cervenka S, Kuja-Halkola R, Matheson GJ, Jönsson EG, Lichtenstein P, Henningsson S, Ichimiya T, Larsson H, Stenkrona P, Halldin C, Farde L.

Mol Psychiatry. 2016 Aug;21(8):1077-84. doi: 10.1038/mp.2015.147. Epub 2015 Oct 6.

PMID:
26821979
41.

In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.

Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, Lekander M, Olgart Höglund C, Kosek E, Lampa J, Halldin C, Farde L, Varrone A, Cervenka S.

Brain Behav Immun. 2016 May;54:149-157. doi: 10.1016/j.bbi.2016.01.019. Epub 2016 Jan 25.

PMID:
26820224
42.

[New findings about schizophrenia can provide new diagnostics and treatment].

Schalling M, Engberg G, Andreassen O, Erhardt S, Cunningham J, Agartz I, Petrovic P, Cervenka S, Fatouros-Bergman H.

Lakartidningen. 2015 Oct 13;112. pii: DH34. Review. Swedish.

43.

Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects.

Collste K, Forsberg A, Varrone A, Amini N, Aeinehband S, Yakushev I, Halldin C, Farde L, Cervenka S.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):173-183. doi: 10.1007/s00259-015-3149-8. Epub 2015 Aug 22.

PMID:
26293827
44.

D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.

Andersson E, Hedman E, Enander J, Radu Djurfeldt D, Ljótsson B, Cervenka S, Isung J, Svanborg C, Mataix-Cols D, Kaldo V, Andersson G, Lindefors N, Rück C.

JAMA Psychiatry. 2015 Jul;72(7):659-67. doi: 10.1001/jamapsychiatry.2015.0546.

PMID:
25970252
45.

["Dialogical floor" can become a trap door].

Guterstam J, Hammarberg A, Finn SW, Cervenka S, Lekander M, Petrovic P, Hedman E.

Lakartidningen. 2015 Mar 12;112. pii: DEEX. Swedish. No abstract available.

46.

Diurnal and seasonal variation of the brain serotonin system in healthy male subjects.

Matheson GJ, Schain M, Almeida R, Lundberg J, Cselényi Z, Borg J, Varrone A, Farde L, Cervenka S.

Neuroimage. 2015 May 15;112:225-231. doi: 10.1016/j.neuroimage.2015.03.007. Epub 2015 Mar 12.

PMID:
25772667
47.

Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.

van der Doef TF, Doorduin J, van Berckel BNM, Cervenka S.

Clin Transl Imaging. 2015;3(6):449-460. doi: 10.1007/s40336-015-0140-0. Epub 2015 Sep 10. Review.

48.

Dopamine D1 receptor availability is related to social behavior: a positron emission tomography study.

Plavén-Sigray P, Gustavsson P, Farde L, Borg J, Stenkrona P, Nyberg L, Bäckman L, Cervenka S.

Neuroimage. 2014 Nov 15;102 Pt 2:590-5. doi: 10.1016/j.neuroimage.2014.08.018. Epub 2014 Aug 16.

PMID:
25134976
49.

Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia.

Fatouros-Bergman H, Cervenka S, Flyckt L, Edman G, Farde L.

Schizophr Res. 2014 Sep;158(1-3):156-62. doi: 10.1016/j.schres.2014.06.034. Epub 2014 Jul 30.

50.

Lacrimal sac dacryoliths (86 samples): chemical and mineralogic analyses.

Komínek P, Doškářová S, Svagera Z, Lach K, Cervenka S, Zeleník K, Matoušek P.

Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):523-9. doi: 10.1007/s00417-013-2501-6. Epub 2013 Oct 30.

PMID:
24170283

Supplemental Content

Loading ...
Support Center